Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To check for Australian drug patents
— Big Pharma, Ireland
To apply for a patent
— Pharmaceutical researcher, USA
To get information on patent expiration dates, in particular composition patents
— Private equity, USA
To identify patent expiration dates
— Medicine sourcing, Malaysia
For paragraph IV challenge research
— Pharmaceutical company, USA
Generated: May 27, 2017
What are the generic sources for prednisolone acetate and what is the scope of prednisolone acetate patent protection?
Prednisolone acetate is the generic ingredient in eighteen branded drugs marketed by Allergan, Cent Pharms, Akorn, Bel Mar, Pfizer, Watson Labs, Schering, Taro, Alcon, Novartis Pharms Corp, Pharmafair, Bausch And Lomb, and Novartis, and is included in twenty-seven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 18 |
| Patents: | 5 |
| Applicants: | 13 |
| NDAs: | 27 |
| Drug Master File Entries: see list | 85 |
| Suppliers / Packagers: see list | 11 |
| Bulk Api Vendors: see list | 40 |
| Clinical Trials: see list | 550 |
| Patent Applications: see list | 3,301 |
| Therapeutic Class: | Ophthalmic Agents |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | prednisolone acetate at DailyMed |
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | ECONOPRED | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Pharmafair | PREDSULFAIR II | prednisolone acetate; sulfacetamide sodium | SUSPENSION/DROPS;OPHTHALMIC | 088837-001 | Dec 24, 1985 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Novartis Pharms Corp | OMNIPRED | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017469-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Schering | METIMYD | prednisolone acetate; sulfacetamide sodium | SUSPENSION/DROPS;OPHTHALMIC | 010210-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | DISCN | No | No | 6,071,523 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To obtain drug patent information
— Patent analyst, India
For information on products (NDAs and ANDAs) that I may be interested in developing, licensing or acquiring
— Executive, specialty pharmaceutical company, USA
To get the patent status of key drugs
— Marketing manager, Chile
To have detail information about patents of branded or generic drug manufactrers.
— Regulatory affairs specialist, Turkey
To research if drugs are still protected with patents or not
— Investment Analyst, France
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
